Cambiar Investors LLC Merck & Co., Inc. Transaction History

Cambiar Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $358,725 - $449,350	-4,963 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$71.68 - $78.83 $2,222 - $2,443	31 Added 0.63%	4,963 $373,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $56,248 - $62,216	800 Added 19.36%	4,932 $384,000
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $48,202 - $56,777	700 Added 20.4%	4,132 $319,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $246,314 - $273,358	3,432 New	3,432 $281,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.